[go: up one dir, main page]

PE42695A1 - Procedimiento para producir proteina c - Google Patents

Procedimiento para producir proteina c

Info

Publication number
PE42695A1
PE42695A1 PE1994257065A PE25706594A PE42695A1 PE 42695 A1 PE42695 A1 PE 42695A1 PE 1994257065 A PE1994257065 A PE 1994257065A PE 25706594 A PE25706594 A PE 25706594A PE 42695 A1 PE42695 A1 PE 42695A1
Authority
PE
Peru
Prior art keywords
production
procedure
case
cell line
protein
Prior art date
Application number
PE1994257065A
Other languages
English (en)
Inventor
Brian William Grinnell
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PE42695A1 publication Critical patent/PE42695A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6464—Protein C (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2523/00—Culture process characterised by temperature

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE REFIERE A UN PROCEDIMIENTO PARA INCREMENTAR LA PRODUCCION DE LA PROTEINA C QUE TIENE ACTIVIDAD ANTICOAGULANTE O PROFIBRINOLITICA; EN UNA CELULA HUESPED MAMIFERA RECOMBINANTE TRANSFORMADA CON ADENOVIRUS TAL COMO: 1) LA LINEA CELULAR HUMAN KIDNEY 293; 2) LA LINEA DE CELULAS SYRIAM HAMSTER AV12; CARACTERIZADO POR COMPRENDER EL CULTIVO DE DICHAS CELULAS A UNA TEMPERATURA DE APROXIMADAMENTE 38°C A 39°C, QUE INCREMENTA EN EL CASO DE (1) LA PRODUCCION DE LA SUSTANCIA C Y EN EL CASO (2) LA PRODUCCION DE MODIFICACIONES POST-TRADUCCION TAL COMO GAMMA-CARBOXILACION DURANTE LA MADURACION NECESARIA PARA LA PRODUCCION DE PROTEINA C ACTIVA
PE1994257065A 1993-12-15 1994-12-14 Procedimiento para producir proteina c PE42695A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/168,035 US5618714A (en) 1993-12-15 1993-12-15 Methods for producing protein C

Publications (1)

Publication Number Publication Date
PE42695A1 true PE42695A1 (es) 1995-12-12

Family

ID=22609820

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1994257065A PE42695A1 (es) 1993-12-15 1994-12-14 Procedimiento para producir proteina c

Country Status (28)

Country Link
US (1) US5618714A (es)
EP (1) EP0658626B1 (es)
JP (1) JP3662614B2 (es)
KR (1) KR950018454A (es)
CN (1) CN1107887A (es)
AT (1) ATE196165T1 (es)
AU (1) AU687914B2 (es)
BR (1) BR9404991A (es)
CA (1) CA2138101A1 (es)
CO (1) CO4340654A1 (es)
CZ (2) CZ315794A3 (es)
DE (1) DE69425809T2 (es)
DK (1) DK0658626T3 (es)
ES (1) ES2149244T3 (es)
FI (1) FI106385B (es)
GR (1) GR3034909T3 (es)
HU (1) HU219508B (es)
IL (1) IL111983A0 (es)
NO (1) NO944846L (es)
NZ (1) NZ270140A (es)
PE (1) PE42695A1 (es)
PL (1) PL176381B1 (es)
PT (1) PT658626E (es)
RU (1) RU2110574C1 (es)
SI (1) SI0658626T1 (es)
UA (1) UA26870C2 (es)
YU (1) YU73494A (es)
ZA (1) ZA949981B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19724543A1 (de) * 1997-06-11 1998-12-17 Philips Patentverwaltung Wechsler-Gerät für Informationsplatten
JP4279554B2 (ja) 2001-02-19 2009-06-17 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｔ細胞エピトープの識別方法および低減された免疫原性を有する分子の製造方法
CA2478901A1 (en) * 2002-03-29 2003-10-16 Merck & Co., Inc. Methods of virus production
US20070142272A1 (en) * 2003-01-24 2007-06-21 Zlokovic Berislav V Neuroprotective activity of activated protein c independent of its anticoagulant activity
EP1773371A4 (en) * 2004-07-23 2009-12-30 Univ Rochester ACTIVATED PROTEIN C INHIBITS SIDE EFFECTS OF PLASMINOGEN ACTIVATOR IN THE BRAIN
CA2612859A1 (en) * 2005-06-23 2006-12-28 The University Of British Columbia Coagulation factor iii polymorphisms associated with prediction of subject outcome and response to therapy
EP2041338A4 (en) * 2006-06-09 2009-09-30 Univ British Columbia INTERFERON GAMMA POLYMORPHISMS AS INDICATORS OF RESULT IN SERIOUSLY SICK SUBJECTS
CA2712057A1 (en) * 2008-01-15 2009-07-23 The University Of British Columbia Protein c rs2069915 as a response predictor to survival and administration of activated protein c or protein c-like compound
WO2012068519A2 (en) 2010-11-19 2012-05-24 Sirius Genomics Inc. Markers associated with response to activated protein c administration, and uses thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4775624A (en) * 1985-02-08 1988-10-04 Eli Lilly And Company Vectors and compounds for expression of human protein C
US4959318A (en) * 1985-06-27 1990-09-25 Zymogenetics, Inc. Expression of protein C
US4968626A (en) * 1985-08-15 1990-11-06 Board Of Reagents Of The University Of Washington DNA sequence coding for protein C
EP0245949B1 (en) * 1986-04-09 1997-10-29 Eli Lilly And Company A method of using eukaryotic expression vectors comprising the bk virus enhancer
EP0289586A4 (en) * 1986-11-17 1990-04-10 New England Medical Ct INCREASING GAMMA CARBOXYLATION OF RECOMBINANT, VITAMIN K-DEPENDENT PROTEINS.
US4992373A (en) * 1987-12-04 1991-02-12 Eli Lilly And Company Vectors and compounds for direct expression of activated human protein C
ZA889497B (en) * 1987-12-28 1990-08-29 Lilly Co Eli Vectors and compounds for expression of zymogen forms of human protein c
JPH0246296A (ja) * 1988-08-09 1990-02-15 Hoechst Japan Ltd 雑種プロテインｃ及びその製造方法
US4981952A (en) * 1988-10-04 1991-01-01 Eli Lilly And Company Method for the purification of vitamin K-dependent proteins
CA1332049C (en) * 1988-10-07 1994-09-20 Eli Lilly And Company Eukaryotic expression
EP0485504B1 (en) * 1989-08-11 1993-12-01 Zymogenetics, Inc. Cell culture methods for producing activated protein c
IL97312A (en) * 1990-02-23 1999-01-26 Lilly Co Eli A method of generating a polypeptide in an eukaryotic vector AND recombinant surrogate cell containing an enhanced transcriptional control unit based on the primary late adenovirus coefficient
JPH05276952A (ja) * 1991-01-29 1993-10-26 Teijin Ltd ヒトプロテインｃ発現ベクター

Also Published As

Publication number Publication date
NO944846L (no) 1995-06-16
GR3034909T3 (en) 2001-02-28
EP0658626A1 (en) 1995-06-21
JP3662614B2 (ja) 2005-06-22
DE69425809T2 (de) 2001-02-01
CA2138101A1 (en) 1995-06-16
NO944846D0 (no) 1994-12-14
CZ315794A3 (en) 1995-10-18
CO4340654A1 (es) 1996-07-30
US5618714A (en) 1997-04-08
YU73494A (sh) 1997-03-07
PT658626E (pt) 2001-01-31
EP0658626B1 (en) 2000-09-06
PL176381B1 (pl) 1999-05-31
RU2110574C1 (ru) 1998-05-10
FI106385B (fi) 2001-01-31
ES2149244T3 (es) 2000-11-01
ATE196165T1 (de) 2000-09-15
SI0658626T1 (en) 2001-02-28
AU687914B2 (en) 1998-03-05
JPH07222589A (ja) 1995-08-22
HUT69979A (en) 1995-09-28
DE69425809D1 (de) 2000-10-12
KR950018454A (ko) 1995-07-22
AU8045294A (en) 1995-06-22
DK0658626T3 (da) 2000-10-16
CN1107887A (zh) 1995-09-06
BR9404991A (pt) 1995-08-08
UA26870C2 (uk) 1999-12-29
HU219508B (hu) 2001-04-28
RU94043769A (ru) 1997-03-27
IL111983A0 (en) 1995-03-15
FI945877A0 (fi) 1994-12-14
CZ290724B6 (cs) 2002-10-16
FI945877L (fi) 1995-06-16
HU9403600D0 (en) 1995-02-28
ZA949981B (en) 1996-06-14
NZ270140A (en) 1996-05-28
PL306291A1 (en) 1995-06-26

Similar Documents

Publication Publication Date Title
PT1318198E (pt) Processo para produzir um polipeptido recombinante que envolve a adicao de um inibidor de quimotripsina ao meio de cultura celular
BR9814568A (pt) "inseminação sexual especìfica de mamìferos com baixo número de células espermatozóides"
PE42695A1 (es) Procedimiento para producir proteina c
DK0654078T3 (da) Thrombinblodfraktion til anvendelse i en medicinsk procedure
DK121788D0 (da) Il-6, fremgangsmaade til dets fremstilling samt dets anvendelse
NL7903542A (nl) Electrochemische cel met gasdepolarisatie; werkwijze voor het beperken van het toetreden van zuurstof bij de kathode van een electrochemische cel met gasdepola-- risatie.
BR9301313A (pt) Esponja heteromorfica bioabsorvivel e metodo para sua preparacao
ES2179351T3 (es) Amidas acidas de piridil alqueno y piridil alquino como citoestaticos e inmunosupresores.
ES2169128T3 (es) Procedimientos para el tratamiento de enfermedades utilizando celulas de sertoli y aloinjertos o xenoinjertos.
AR008305A1 (es) Guanidinas de acidos alquenil-carboxilicos sustituidos con fenilo, procedimientos para su preparacion, su utilizacion como medicamento o agente dediagnostico, asi como un medicamento que las contiene
EE03955B1 (et) Nukleiinhappe kasutamine ravimi valmistamiseks imetaja reproduktiivtrakti vähemalt mõne raku transfekteerimiseks
AR036827A1 (es) Queratinocitos utilizables como sustancia biologicamente activa en el tratamiento de heridas
ATE252825T1 (de) Verlängerte lagerung roter blutzellen
SE8701921L (sv) Ny farmaceutisk anvendning
ES2046176T3 (es) Composicion farmaceutica que contiene una asociacion de colageno y de un principio activo antiseptico y/o antiinflamatorio y su procedimiento de fabricacion.
ES2056294T3 (es) (quinolin-2-il-metoxi)fenil-acil-sulfonamidas y -cianamidas substituidas, procedimiento para su obtencion y su empleo en medicamentos.
MX9704050A (es) P-amidinobencilamidas de dipeptido novedosas con radicales sulfonilo o aminosulfonilo en terminal n.
ES8304569A1 (es) Un procedimiento para la preparacion de una sal soluble en agua de lisina o arginina del 1,1-dioxido de n-(2-piridil)-2-metil-4-hidroxi-2h-1,2-benzotiazin-3-carboxamida.
NO975545L (no) Cellelinje som produserer analgetiske forbindelser for behandling av smerte
DK0414019T3 (da) Substituerede N-(quinolin-2-yl-methoxy)benzyl-sulfonylurinstoffer
TR200103004T2 (tr) Pirolidinkarbonilamino siklik disülfitler.
DE60140015D1 (de) Kombination von Defibrotide und G-CSF und ihre Verwendung zur Aktivierung hämatopoietischer Vorläuferzellen
SE7707889L (sv) Haptoglobinpreparat
DE60043888D1 (de) Oberfläche für zellkultur
ES2169124T3 (es) Acido 4-aminomicofenolico 6-sustituido y derivados con actividad inmunosupresora.

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed